Clinical trial data: Vortioxetine (Trintellix) at 30mg - 40mg

Sdílet
Vložit
  • čas přidán 9. 06. 2023
  • A clinical trial for treatment resistant depression (TRD) demonstrating broad tolerability of vortioxetine (Trintellix, Brintellix) at "supratherapeutic" dosages of 30mg and 40mg.
    Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression
    www.psychiatrist.com/pcc/depr...
    By: Daniel Rosehill (‪@DanielSRosehill‬)
    --
    This channel represents my small attempt to reduce the stigma surrounding depression and anxiety, particular among younger males. If you're curious about me, or want to get in touch, please feel free to do so via my personal website (danielrosehill.com) or through my main CZcams channel (danielrosehill.com/youtube).

Komentáře • 3